Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001193125-25-314624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-10 | 2025-12-08 | LMAT | Kamke Trent G | Senior V. P, Ops | F - Tax | $82.93 | -169 | 3,570 | -5% | -$14.0K |
| DM | 2025-12-10 | 2025-12-08 | LMAT | Kamke Trent G | Senior V. P, Ops | M - OptEx | $0.00 | +9 | 3,647 | +0.2% | $0 |
| DM | 2025-12-10 | 2025-12-08 | LMAT | Kamke Trent G | Senior V. P, Ops | M - OptEx | $0.00 | -9 | 9.71 | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-08 | F | D | 92 | $82.93 | 3,483 | D | — | — | (F3) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 2 | Common | Common Stock | 2025-12-08 | M | A | 5 | $0.00 | 3,575 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 3 | Common | Common Stock | 2025-12-08 | M | A | 4 | $0.00 | 3,647 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 4 | Common | Common Stock | 2025-12-08 | F | D | 77 | $82.93 | 3,570 | D | — | — | (F2) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/8/2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 5 | Derivative | Dividend Equivalent Rights | 2025-12-08 | M | D | 4 | $0.00 | 9.28 | D | — · — to — | 4 Common Stock | (F4) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| 6 | Derivative | Dividend Equivalent Rights | 2025-12-08 | M | D | 5 | $0.00 | 9.71 | D | — · — to — | 5 Common Stock | (F5) These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |